Lilly Wong
University of North Carolina at Chapel Hill
ORCID: 0000-0001-7460-8658Also affiliated with Fate Therapeutics (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 11 papers. Top paper: “Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial”.
Veronika Bachanova, Krish Patel, Jae H Park, Ian Flinn, Peter A Riedell +12 more
Januario Castro, Aaron Goodman, Veronika Bachanova, Manali Kamdar, Farrukh T Awan +11 more
Lilly Wong, Yuyang Tang, Brigitte Allard, Katherine S. James, George R. Thompson +8 more
Lilly Wong, Kendra Ellis, Brittany Bodnar, Sami Saribas, Julia Ting +10 more
Dajiang Li, Yuyang Tang, Gema Méndez‐Lagares, George R. Thompson, Dennis J. Hartigan-O’Connor +3 more
Guochun Jiang, Lilly Wong
Dajiang Li, Shane D. Falcinelli, Lilly Wong, Yuyang Tang, Edward P. Browne +3 more
Antoine Chaillon, Sara Gianella, Lilly Wong, Dajiang Li, Theresa L. Simermeyer +23 more
Guochun Jiang, Dajiang Li, David M. Margolis, Nancie M. Archin, Xi Chen +6 more
Jianfeng Chen, Ying Wang, Lilly Wong, Zhichuan Zhu, Guochun Jiang +2 more
Morgan Dewey, Li Wang, Shane D. Falcinelli, Lilly Wong, Yuyang Tang +6 more